Nurix Therapeutics, Inc. vs NeOnc Technologies Holdings, In — Valuation Comparison 2026
Access all valuation models for NRIX vs NTHI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →NRIX scores higher with a 6.4/10 quality rating vs NTHI's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Nurix Therapeutics, Inc. (NRIX) and NeOnc Technologies Holdings, In (NTHI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
NRIX currently trades at $17.67 with a QOC of 6.4/10, while NTHI trades at $4.79 with a QOC of 3.7/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).